Projects per year
Personal profile
Personal profile
Tetsuo Ashizawa, MD, formerly the executive director of the McKnight Brain Institute at the University of Florida, organized and developed interdisciplinary neuroscience research programs involving multiple colleges and departments. He also chaired the neurology department at the University of Texas Medical Branch and at the University of Florida, where he supervised the clinical care of and research in a variety of neurological disorders.
As a physician-scientist, some of Dr. Ashizawa’s current research is funded by the National Institutes of Health, the Muscular Dystrophy Association and the Myotonic Dystrophy Foundation. He is studying neurogenetic disorders caused by expansions of DNA sequences that are connected end-to-end and abnormally repeated, such as myotonic dystrophies, spinocerebellar ataxias, Friedreich’s ataxia, and Huntington’s disease.
Dr. Ashizawa received his medical degree from the Keio University School of Medicine in Tokyo. After moving to the U.S., he completed his neurology residency and Muscular Dystrophy Association fellowships in neurochemistry and clinical neuromuscular disorders at Baylor College of Medicine.
Dr. Ashizawa is board certified in neurology by the American Board of Psychiatry and Neurology. He serves on multiple grant review panels, including NIH study sections, and on the scientific advisory boards of the Myotonic Dystrophy Foundation, the National Ataxia Foundation, and the Association Française contre les Myopathies.
Education/Academic qualification
Neuromuscular Disorders, Fellow, Baylor College of Medicine
1978 → 1979
Neurology, Residency, Baylor College of Medicine
1975 → 1978
Medicine, MD, Keio University School of Medicine
1969 → 1973
Research Area Keywords
- Neurosciences
Fingerprint
- 4 Similar Profiles
Network
Projects
-
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1: END-DM1
Greene, E. P., Ashizawa, T., Shroff, S. & Thonhoff, J. R.
12/17/19 → …
Project: Clinical Trial
-
-
Genetic mechanism of conserved ancestral haplotype in SCA10
Ashizawa, T. & Peterson, L. E.
2/1/19 → 12/31/23
Project: Federal Funding Agencies
-
-
Clinical Trial Readiness for SCA1 and SCA3
Ashizawa, T. & Peterson, L. E.
1/1/18 → 12/31/22
Project: Federal Funding Agencies
Research Output
-
A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1
Zhang, N., Bewick, B., Xia, G., Furling, D. & Ashizawa, T., Dec 10 2020, In : Frontiers in Genetics. 11, 13 p., 594576.Research output: Contribution to journal › Article
-
Analysis of diffusion tensor parameters in spinocerebellar ataxia type 3 and type 10 patients
Meira, A. T., Arruda, W. O., Ono, S. E., Franklin, G. L., de Carvalho Neto, A., Raskin, S., Ashizawa, T., Camargo, C. H. F. & Teive, H. A. G., Sep 2020, In : Parkinsonism and Related Disorders. 78, p. 73-78 6 p.Research output: Contribution to journal › Article
-
Balance and physical functioning in Spinocerebellar ataxias 3 and 10
Konno, K. M., Zonta, M. B., Guimarães, A. T. B., Camargo, C. H. F., Munhoz, R. P., Raskin, S., Ashizawa, T. & Teive, H. A. G., Nov 29 2020, In : Acta Neurologica Scandinavica.Research output: Contribution to journal › Article
-
Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group
Leite, C. D. M. B. A., Schieferdecker, M. E. M., Frehner, C., Munhoz, R. P., Ashizawa, T. & Teive, H. A. G., Jan 2 2020, In : Nutritional Neuroscience. 23, 1, p. 49-54 6 p.Research output: Contribution to journal › Article
2 Scopus citations -
Cancer frequency in patients with spinocerebellar ataxia type 10
Schultz, D. B., Nascimento, F. A., Camargo, C. H. F., Ashizawa, T. & Teive, H. A. G., Jul 2020, In : Parkinsonism and Related Disorders. 76, p. 1-2 2 p.Research output: Contribution to journal › Letter
Prizes
-
DNAzymes for cleaving CAG repeat RNA and eliminating viral RNA
Zhang, Nan (Recipient) & Ashizawa, Tetsuo (Recipient), Nov 11 2020
Prize: Prize (including medals and awards)